Trials / Conditions / Lung Transplant Failure and Rejection

Lung Transplant Failure and Rejection

12 registered clinical trials studyying Lung Transplant Failure and Rejection — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD NCT07434869	Brian Keller	—
Recruiting	Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO NCT06679257	Jesper Magnusson	—
Recruiting	Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation NCT04837339	Hopital Foch	N/A
Active Not Recruiting	AlloSure Lung Assessment and Metagenomics Outcomes Study NCT05050955	CareDx	—
Enrolling By Invitation	Long Term Follow up of the LTOG Cohort NCT04787822	University of Pennsylvania	—
Completed	Comparison of Transbronchial Cryobiopsy and Forceps Biopsy in Lung Transplant Recipients NCT05006742	University of Zurich	N/A
Terminated	Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation NCT04318587	Pablo Sanchez	N/A
Enrolling By Invitation	Trajectories of FEV1 After Lung Transplantation NCT05934617	Paris Translational Research Center for Organ Transplantation	—
Completed	Clinical Trials in Organ Transplantation Extension Study NCT04126746	Duke University	—
Terminated	CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation NCT04558333	University Hospital, Antwerp	—
Completed	Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BO NCT03656926	Zambon SpA	Phase 3
Completed	Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BO NCT03657342	Zambon SpA	Phase 3